5-ethyl-3-hydrazino-5H-1,2,4-triazino<5,6-b>indole | 49830-45-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-ethyl-3-hydrazino-5H-1,2,4-triazino<5,6-b>indole
• 英文别名: 5-ethyl-3-hydrazino-1,2,4-triazino[5,6-b]indole；(5-ethyl-5H-1,2,4-triazino[5,6-b]indol-3-yl)-hydrazine；5-ethyl-3-hydrazino-5H-1,2,4-triazino[5,6-b]indole；5-ethyl-3-hydrazino-5H-[1,2,4]triazino[5,6-b]indole；(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)hydrazine
• CAS: 49830-45-7
• 化学式: C₁₁H₁₂N₆
• 分子量: 228.256
• InChiKey: XYDZEWLSHNZMFH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  81.6
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-ethyl-3-hydrazino-5H-1,2,4-triazino<5,6-b>indole 在 溶剂黄146 、 sodium nitrite 作用下， 反应 2.0h， 以63%的产率得到10-Ethyl-10H-tetrazolo<5',1':3,4><1,2,4>triazino<5,6-b>indole
  参考文献：
  名称：

  Younes, Mansour I.; Abbas, Hessan H.; Metwally, Saoud A., Archiv der Pharmazie, 1987, vol. 320, # 12, p. 1191 - 1195

  摘要：

  DOI：
• 作为产物：
  描述：

  ethyl 5-amino-1-(5-ethyl-5H-1,2,4-triazino<5,6-b>indol-3-yl)-1H-pyrazole-4-carboxylate 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 8.0h， 以76%的产率得到5-ethyl-3-hydrazino-5H-1,2,4-triazino<5,6-b>indole
  参考文献：
  名称：

  Younes; Abbas; Metwally, Pharmazie, 1991, vol. 46, # 2, p. 98 - 100

  摘要：

  DOI：

文献信息

• [EN] TRIAZINE COMPOUNDS AND THEIR USE<br/>[FR] COMPOSES DE TRIAZINE ET LEUR UTILISATION
  申请人：NOVO PHARMACEUTICALS LTD DE

  公开号：WO2004096808A1

  公开（公告）日：2004-11-11

  A compound of formula (I) wherein R1 is hydrogen, alkyl, -alkyl-aryl, -alkyl-heterocycloalkyl or -alkyl-0-heterocycloalkyl; R2 is hydrogen, hydroxy, amino, nitro, alkoxy, alkyl, aryl or heteroaryl; R3 is hydrogen, alkyl or aryl; R4 is hydrogen, alkyl, aryl, heteroaryl, -CH(aryl)2, -alkyl-aryl or -C(0)0-alkyl; and R5 is alkyl, hydroxy or amino; or a pharmaceutically acceptable salt thereof; is new for use in therapy, e.g. in the treatment of Alzheimer's disease.

  式（I）的化合物中，其中R1是氢，烷基，-烷基-芳基，-烷基-杂环烷基或-烷基-0-杂环烷基；R2是氢，羟基，氨基，硝基，烷氧基，烷基，芳基或杂芳基；R3是氢，烷基或芳基；R4是氢，烷基，芳基，杂芳基，-CH（芳基）2，-烷基-芳基或-C（0）0-烷基；R5是烷基，羟基或氨基；或其药用可接受盐；用于治疗，例如用于治疗阿尔茨海默病。
• [EN] 1,2,4-TRIAZIN-3-YL-HYDRAZINE OR 5H-1,2,4-TRIAZINO'5,6-B!INDOL-3-YL-HYDRAZINE COMPOUNDS AS INHIBITORS OF BACE USEFUL IN THE TREATMENT OF ALZHEIMER<br/>[FR] COMPOSES 1,2,4-TRIAZIN-3-YL-HYDRAZINE OU 5H-1,2,4-TRIAZINO[5,6-B]INDOL-3-YL-HYDRAZINE UTILISES COMME INHIBITEURS DE BACE UTILES DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
  申请人：NOVO PHARMACEUTICALS LTD DE

  公开号：WO2004063196A1

  公开（公告）日：2004-07-29

  A compound of formula (I) wherein R1 is aryl and R2 is hydrogen; or R1 and R2 taken together form a group of formula (i) wherein R6 is alkyl or -alkyl-aryl; and R7 is hydrogen, halogen, alkyl, alkoxy or aryl; R3 is aryl, heteroaryl or -aryl-aryl; R4 is hydrogen, hydroxy or alkyl; and R5 is hydrogen or alkyl; or a pharmaceutically acceptable salt thereof, is new, for use in therapy, e.g. of Alzheimer's disease.

  公式（I）的化合物，其中R1为芳基，R2为氢；或者R1和R2结合形成公式（i）中的一个基团，其中R6为烷基或-烷基-芳基；而R7为氢、卤素、烷基、烷氧基或芳基；R3为芳基、杂环芳基或-芳基-芳基；R4为氢、羟基或烷基；而R5为氢或烷基；或其药用可接受盐，用于治疗，例如阿尔茨海默病。
• Synthesis and Reactions of Triazine Azide towards Nucleophilic Reagents
  作者：H. H. Abbas Temerik、M. I. Younes、S. A. Metwally

  DOI：10.1135/cccc19933017

  日期：——

  The hydrazinotriazine compound I was used for preparation of various fused heterocycles.

  使用肼三嗪化合物I制备各种融合杂环。
• Sterically Controlled Regiospecific Cyclization of Aldose-5-ethyl-1,2,4-triazino[5,6-b]indol-3-ylhydrazones to Linearly Annelated 3-Polyhydroxyalkyl-10-ethyl-1,2,4-triazolo-[4′,3′:2,3]-1,2,4-triazino[5,6-b]indoles
  作者：Mohammed A. E. Shaban、Mamdouh A. M. Taha、Ali E. A. Morgaan

  DOI：10.1007/pl00010316

  日期：2000.5.17

  Condensation of aldoses with 5-ethyl-3-hydrazino-1,2,4-triazino[5,6-b]indole gave the corresponding aldose-5-ethyl-1,2,4-triazino[5,6-b]indol-3-ylhydrazones which were acetylated to their poly-O-acetyl derivatives. The latter underwent sterically controlled regiospecific oxidative cyclization with bromine in acetic acid and sodium acetate to sterically favourable linearly annelated 3-polyacetoxyalkyl-10-ethyl-1,2,4-triazole[4',3':2,3]-1,2,4-triazino[5,6-b]indoles rather than to their sterically unfavourable angularly annelated regioisomers. The regiospecific outcome of this heterocyclization is discussed in terms of electronic as well as steric factors, and the assigned structures have been corroborated on the basis of chemical as well as spectroscopic evidence. De-O-acetylation of the acetoxyindoles with ammonium hydroxide in methanol gave the title compounds. Representative members of the prepared compounds were tested for antimicrobial activity.
• Younes, Mansour I.; Abdel-Alim, Alim M.; Abbas, Hessan H., Archiv der Pharmazie, 1987, vol. 320, # 12, p. 1196 - 1202
  作者：Younes, Mansour I.、Abdel-Alim, Alim M.、Abbas, Hessan H.、Metwally, Saoud A.

  DOI：——

  日期：——